You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ONC201

Showing 1 - 25 of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)

Not yet recruiting
  • Meningioma
  • +2 more
  • ONC201
  • Omaha, Nebraska
    University of Nebraska Medical Center
Aug 21, 2023

H3 K27M, Glioma Trial in Santa Monica (ONC201, ONC201 + Placebo, Placebo)

Recruiting
  • H3 K27M
  • Glioma
  • ONC201
  • +2 more
  • Santa Monica, California
    Providence Saint John's Cancer Institute
Nov 28, 2022

Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)

Completed
  • Recurrent Neuroendocrine Tumor
  • Metastatic Neuroendocrine Tumor
  • ONC201
  • Cleveland, Ohio
    Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
Dec 1, 2022

Endometrial Cancer, Metastasis Trial (Atezolizumab, ONC201)

Not yet recruiting
  • Endometrial Cancer
  • Metastasis
  • (no location specified)
Sep 12, 2022

Colorectal Adenomatous Polyp, Colorectal Carcinoma, Familial Adenomatous Polyposis Trial in United States (procedure, drug,

Not yet recruiting
  • Colorectal Adenomatous Polyp
  • +3 more
  • Biopsy
  • +5 more
  • Ann Arbor, Michigan
  • +4 more
Jan 3, 2023

Metastatic Colorectal Cancer Trial in Providence (Dose level 1 ONC201 625mg, Dose level 2 ONC201 500mg, Dose level 3 ONC201

Terminated
Has Results
  • Metastatic Colorectal Cancer
  • Dose level 1 ONC201 625mg
  • +2 more
  • Providence, Rhode Island
    Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals
May 25, 2022

Triple Negative Breast Cancer Trial in Madison (Akt/ERK Inhibitor ONC201, Methionine-Restricted Diet)

Terminated
Has Results
  • Triple Negative Breast Cancer
  • Akt/ERK Inhibitor ONC201
  • Methionine-Restricted Diet
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Feb 11, 2022

Acute Myeloid Leukemia, MDS Trial in Omaha (ONC201)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • ONC201
  • Omaha, Nebraska
    University of Nebraska Medical Center
Aug 4, 2022

Glioma Trial in Philadelphia (ONC201)

No longer available
  • Glioma
  • ONC201
  • Philadelphia, Pennsylvania
    Oncoceutics
Mar 10, 2022

CNS Lymphoma, Gastric Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Houston (Akt/ERK Inhibitor ONC201,

Terminated
Has Results
  • Central Nervous System Lymphoma
  • +6 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 30, 2022

Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Malignant Ovarian Epithelial Tumor
  • +9 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 10, 2022

Glioma Trial in United States (ONC201)

Active, not recruiting
  • Glioma
  • ONC201
  • San Francisco, California
  • +8 more
Jul 14, 2022

Glioma Trial in United States (ONC201)

No longer available
  • Glioma
  • ONC201
  • San Francisco, California
  • +9 more
May 19, 2022

Glioblastoma, Diffuse Midline Glioma, H3 K27M Glioma Trial in United States (ONC201)

Active, not recruiting
  • Glioblastoma
  • +5 more
  • ONC201
  • Los Angeles, California
  • +4 more
Apr 8, 2022

Triple Negative Breast Cancer, Endometrial Cancer, Hormone Receptor Positive, HER2 Negative Breast Cancer Trial run by the

Completed
Has Results
  • Triple Negative Breast Cancer
  • +2 more
  • ONC201
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 17, 2021

Diffuse Intrinsic Pontine Glioma, Glioma, Malignant Trial in United States (ONC201)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Glioma, Malignant
  • ONC201
  • San Francisco, California
  • +7 more
Mar 1, 2022

Glioma, H3 K27M Trial in United States (ONC201)

Available
  • Glioma
  • H3 K27M
  • ONC201
  • Phoenix, Arizona
  • +21 more
Sep 23, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Villejuif (Everolimus, ONC201, Radiotherapy)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 27, 2022

Glioblastoma Trial in Minneapolis (ONC201)

Withdrawn
  • Glioblastoma
  • ONC201
  • Minneapolis, Minnesota
    University of Minnesota
Apr 28, 2021

Advanced Solid Tumors, Multiple Myeloma Trial in Philadelphia (ONC-201)

Completed
  • Advanced Solid Tumors
  • Multiple Myeloma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jun 2, 2021

Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma Trial in Los Angeles (drug, radiation,

Withdrawn
  • Recurrent Glioblastoma
  • +3 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 10, 2021

Advanced Glioblastoma, Advanced Colorectal Cancer, Advanced Triple-negative Breast Cancer Trial in Boston (ONC201)

Withdrawn
  • Advanced Glioblastoma
  • +3 more
  • ONC201
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 28, 2021

Multiple Myeloma Trial in New York (ONC201, Ixazomib, Dexamethasone)

Terminated
  • Multiple Myeloma
  • ONC201
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 27, 2020

Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)

Completed
  • Advanced Solid and Hematological TP53wt Tumors
  • Boston, Massachusetts
  • +14 more
May 20, 2021

Solid Tumors Trial in New Brunswick (Oral ONC201)

Completed
  • Solid Tumors
  • Oral ONC201
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
May 20, 2019